Compare HRMY & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRMY | HUN |
|---|---|---|
| Founded | 2017 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2020 | 2005 |
| Metric | HRMY | HUN |
|---|---|---|
| Price | $35.24 | $10.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | ★ $50.56 | $10.00 |
| AVG Volume (30 Days) | 934.4K | ★ 6.1M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 9.92% |
| EPS Growth | ★ 50.44 | N/A |
| EPS | ★ 3.17 | N/A |
| Revenue | $825,944,000.00 | ★ $5,780,000,000.00 |
| Revenue This Year | $20.68 | N/A |
| Revenue Next Year | $15.93 | $4.44 |
| P/E Ratio | $11.14 | ★ N/A |
| Revenue Growth | ★ 21.13 | N/A |
| 52 Week Low | $25.52 | $7.30 |
| 52 Week High | $40.93 | $20.94 |
| Indicator | HRMY | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 70.22 |
| Support Level | $32.77 | $8.04 |
| Resistance Level | $36.20 | $8.97 |
| Average True Range (ATR) | 1.11 | 0.47 |
| MACD | 0.17 | 0.25 |
| Stochastic Oscillator | 81.04 | 98.75 |
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.